Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Workday Inc — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B), while Workday Inc trades at $188 (market cap $44.41B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is the larger of the two by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Workday Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Workday Inc for 38 Days on average.
| TAK | WDAY | |
|---|---|---|
Market Cap | $58.16B | $44.41B |
Volume | 2,467,530 | 1,519,068 |
Sector | Health | Technology |
52-Week High | $19.05 | $245.67 |
52-Week Low | $13.23 | $112.55 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $86.04B | $44.78B |
Dividend Yield | 3.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Workday (WDAY) trades at $184.26, down 1.23% on the day, amid a broader tech selloff. The stock shows bearish technical signals with support at $182 and resistance at $187. Fundamentally, WDAY reported strong Q2 2026 EPS of $2.75, beating estimates, with revenue growth projected to reach $10.2B in 2026. Recent news includes strategic layoffs, AI product launches, and expansion in the UAE, highlighting its focus on enterprise AI solutions.
WDAY's outlook is supported by robust AI-driven revenue growth and a 50.6% analyst buy rating, with a consensus price target of $202.92 offering ~10% upside. Risks include integration costs from restructuring, competitive pressures in HR/finance software, and market volatility. The stock remains a compelling growth play if execution on AI monetization continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
